Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity.

ABSTRACT:

SUBMITTER: Moin ASM 

PROVIDER: S-EPMC7510340 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature